Sivik Global Healthcare as of Dec. 31, 2016
Portfolio Holdings for Sivik Global Healthcare
Sivik Global Healthcare holds 56 positions in its portfolio as reported in the December 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| iShares NASDAQ Biotechnology Index (IBB) | 4.4 | $9.3M | 35k | 265.37 | |
| Humana (HUM) | 3.7 | $7.8M | 38k | 204.03 | |
| Celgene Corporation | 3.7 | $7.8M | 68k | 115.75 | |
| Aetna | 3.5 | $7.4M | 60k | 124.02 | |
| AstraZeneca | 3.5 | $7.4M | 270k | 27.32 | |
| Alexion Pharmaceuticals | 3.5 | $7.3M | 60k | 122.35 | |
| Bristol Myers Squibb (BMY) | 3.5 | $7.3M | 125k | 58.44 | |
| UnitedHealth (UNH) | 3.4 | $7.2M | 45k | 160.04 | |
| Anthem (ELV) | 3.4 | $7.2M | 50k | 143.78 | |
| Centene Corporation (CNC) | 3.4 | $7.1M | 125k | 56.51 | |
| Merck & Co (MRK) | 3.2 | $6.8M | 115k | 58.87 | |
| CIGNA Corporation | 3.2 | $6.7M | 50k | 133.39 | |
| Regeneron Pharmaceuticals (REGN) | 3.1 | $6.4M | 18k | 367.09 | |
| Gilead Sciences (GILD) | 2.7 | $5.7M | 80k | 71.61 | |
| Biogen Idec (BIIB) | 2.7 | $5.7M | 20k | 283.60 | |
| Incyte Corporation (INCY) | 2.6 | $5.5M | 55k | 100.27 | |
| WellCare Health Plans | 2.6 | $5.5M | 40k | 137.08 | |
| BioMarin Pharmaceutical (BMRN) | 2.4 | $5.0M | 60k | 82.83 | |
| McKesson Corporation (MCK) | 2.4 | $4.9M | 35k | 140.46 | |
| Molina Healthcare (MOH) | 2.3 | $4.9M | 90k | 54.26 | |
| C.R. Bard | 2.1 | $4.5M | 20k | 224.65 | |
| Becton, Dickinson and (BDX) | 2.0 | $4.1M | 25k | 165.56 | |
| Johnson & Johnson (JNJ) | 1.9 | $4.0M | 35k | 115.20 | |
| AmerisourceBergen (COR) | 1.9 | $3.9M | 50k | 78.20 | |
| Boston Scientific Corporation (BSX) | 1.8 | $3.8M | 175k | 21.63 | |
| Universal Health Services (UHS) | 1.8 | $3.7M | 35k | 106.37 | |
| Gw Pharmaceuticals Plc ads | 1.5 | $3.1M | 28k | 111.73 | |
| Henry Schein (HSIC) | 1.4 | $3.0M | 20k | 151.69 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 1.4 | $2.9M | 40k | 73.68 | |
| Thermo Fisher Scientific (TMO) | 1.4 | $2.8M | 20k | 141.10 | |
| ResMed (RMD) | 1.3 | $2.8M | 45k | 62.04 | |
| Vwr Corp cash securities | 1.3 | $2.8M | 110k | 25.03 | |
| Smith & Nephew (SNN) | 1.2 | $2.6M | 85k | 30.08 | |
| Chemed Corp Com Stk (CHE) | 1.1 | $2.4M | 15k | 160.40 | |
| IDEXX Laboratories (IDXX) | 1.1 | $2.3M | 20k | 117.25 | |
| Dentsply Sirona (XRAY) | 1.1 | $2.3M | 40k | 57.72 | |
| Eli Lilly & Co. (LLY) | 1.1 | $2.2M | 30k | 73.57 | |
| VCA Antech | 1.0 | $2.1M | 30k | 68.67 | |
| ACADIA Pharmaceuticals (ACAD) | 1.0 | $2.0M | 70k | 28.84 | |
| PAREXEL International Corporation | 0.9 | $2.0M | 30k | 65.73 | |
| Intuitive Surgical (ISRG) | 0.9 | $1.9M | 3.0k | 634.33 | |
| Hologic (HOLX) | 0.8 | $1.6M | 40k | 40.12 | |
| Wright Medical Group Nv | 0.8 | $1.6M | 70k | 22.99 | |
| Agilent Technologies Inc C ommon (A) | 0.8 | $1.6M | 35k | 45.57 | |
| LHC | 0.8 | $1.6M | 35k | 45.71 | |
| Edwards Lifesciences (EW) | 0.7 | $1.4M | 15k | 93.73 | |
| Impax Laboratories | 0.7 | $1.4M | 105k | 13.25 | |
| Sage Therapeutics (SAGE) | 0.5 | $1.0M | 20k | 51.05 | |
| Neurocrine Biosciences (NBIX) | 0.5 | $968k | 25k | 38.72 | |
| Amedisys (AMED) | 0.4 | $917k | 22k | 42.63 | |
| Puma Biotechnology (PBYI) | 0.4 | $921k | 30k | 30.70 | |
| Bluebird Bio | 0.4 | $926k | 15k | 61.73 | |
| Kite Pharma | 0.4 | $807k | 18k | 44.83 | |
| Clovis Oncology | 0.3 | $666k | 15k | 44.40 | |
| Seattle Genetics | 0.0 | $0 | 0 | 0.00 | |
| Baxter International (BAX) | 0.0 | $0 | 0 | 0.00 |
